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Studies on curcumin, the principal element of turmeric powder, have demonstrated several biological 
actions such as antibacterial activity. Evaluation of new analogs or new compounds of curcumin for their 
antibacterial effect is interesting for researchers. In this in vitro study, we attempted to test the 
antibacterial activity of indium curcumin (In(CUR)3), indium diacetylcurcumin (In(DAC)3), and 
diacetylcurcumin (DAC) in comparison with curcumin. The action of these agents were examined on 
Staphylococcus aureus (ATCC 25923), Staphylococcus epidermidis (ATCC 14990), Pseudomonas 
aeruginosa (ATCC 27853), and Escerichia coli (ATCC 25922). Curcumin was effective against S. aureus 
and S. epidermidis, whereas In(DAC)3 showed activity against S. epidermidis and P. aeruginosa. The 
effect of In(DAC)3 on P. aeruginosa is an advantage. Strikingly, In(CUR)3 exhibited antibacterial activity 
on all the four mentioned strains. DAC did not show antibacterial effect on any of the four test bacteria. 
The minimum inhibitory concentration (MIC) of curcumin was 187.5 µg/ml for S. aureus, and 46.9 µg/ml 
for S. epidermidis. However, the MIC of In(CUR)3 was lower for the same bacterial strains (93.8 µg/ml for 
S.aureus and 23.4 µg/ml for S. epidermidis). Therefore, In(CUR)3 was found to have more antibacterial 
effect than curcumin itself and could be a suitable candidate for further in vivo investigations. 
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INTRODUCTION 
 
Development of bacterial resistance to the available 
antibiotics and increasing popularity of traditional medicine 
has led researchers to investigate the antibacterial 
compounds in plants. Curcuma longa is a medicinal plant 
that botanically is related to Zingberiaceae family 
(Chattopadhyay et al., 2004). Turmeric powder, derived 
from the rhizome of C. longa, is commonly used as a 
spice, food preservative, and food-coloring agent 
(Aggarwall et al., 2007; Di Mario et al., 2007; Menon and 
Sudheer, 2007). It also has a long history of therapeutic 
use (Chattopadhyay et al., 2004). Curcumin [1,7-bis 
(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione; 
Diferuloylmethane], a yellow bioactive pigment, is the 
major component of  turmeric  (Mohammadi  et  al.,  2005;  
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Menon and Sudheer, 2007; Hatcher et al., 2008). It has 
been shown that curcumin have a wide spectrum of 
biological actions such as anti-inflammatory (Punithavathi 
et al., 2000; Siddiqui et al., 2006), antioxidant 
(Mohammadi et al., 2005; Menon and Sudheer, 2007), 
anticancer (LoTempio et al., 2005), antidiabetic (Aggarwal 
et al., 2007), antiallergic (Suzuki et al., 2005), antiviral (Si 
et al., 2007), antiprotozoal (Reddy et al., 2005) and 
antifungal activities (Chattopadhyay et al., 2004). 
Moreover, anti- bacterial activity of curcumin has been 
reported (Chattopadhyay et al., 2004; Di Mario et al., 2007; 
Rai et al., 2008).                                
Synthetic modification of previously described antibac- 
terial agents has been prominent in the development of 
new compounds which may possess an enhanced 
antibacterial activity or new pharmacological properties. 
There are reports on synthesis of mono-carbonyl 
analogues of curcumin (Liang et al., 2008) or preparation 
of bioactive conjugates of curcumin (Dubey et al., 2007) in  
  
 
 
order to increase antimicrobial and anticancer activity. 
Furthermore, it has been shown that indium curcumin 
complex (a metal complex of curcumin), diacetylcurcumin, 
and indium diacetylcurcumin have anticancer activity 
(Mohammadi et al., 2005). The objective of the present 
study was to evaluate the antibacterial activity of indium 
curcumin, indium diacetylcurcumin, and diacetylcurcumin 
compared with curcumin.                                                                         
 
 
MATERIALS AND METHODS 
 
Bacterial strains and maintenance procedure 
 
Staphylococcus aureus (ATCC 25923), Staphylococcus epidermidis 
(ATCC 14990), Psudomonas aeruginosa (ATCC 27853), and 
Escherichia coli (ATCC 25922) were used as test organisms. The 
strains were cultured on brain heart agar (Merck, Germany). 
Afterwards, grown bacterial colonies were picked from the plate, 
suspended in sterile skim milk (Merck, Germany) containing 10% 
glycerol (Merck, Germany) and stored at -20ºC.   
 
 
Antibacterial activity assay 
 
The test agents in this study were curcumin, indium curcumin 
(In(CUR)3), indium diacetylcurcumin (In(DAC)3) and diacetylcur- 
cumin (DAC). Curcumin (Sigma) was purchased and then, DAC, 
In(CUR)3, and In(DAC)3 were prepared as previously described 
(Mohammadi et al., 2005). Stock solution of the test agents were 
made up in DMSO (dimethylsulfoxide; Merck, Germany) to ensure 
complete solubilization (Mohammadi et al., 2005; Liang et al., 2008). 
The fresh culture of aforementioned strains was prepared and 
antibacterial activity of each test agent against each bacterium was 
examined as follows: in the test tube containing Mueller Hinton broth 
(Merck, Germany), a bacterial concentration of 5 × 105 colony 
forming units (CFU)/ml (Forbes et al., 2007) was tested with 375 
µg/ml of the test agent. Moreover, a tube of the Mueller Hinton broth 
containing the same bacterial concentration, but without the test 
agent, was used as growth control, and another tube of the 
uninoculated Mueller Hinton broth containing the same concentration 
of test agent was used as negative growth control (Forbes et al., 
2007). Also, a tube of Mueller Hinton broth containing the same 
bacterial concentration and DMSO, but without test agent, was 
prepared to control and rule out antibacterial effect of DMSO in the 
test tube. The test tube and three mentioned control tubes were 
incubated at 37ºC for 24 h. After incubation, antibacterial activity of 
test agent in the test tube was detected by lack of turbidity (matching 
the negative growth control) which indicating the inhibition of 
bacterial growth (Talaro and Talaro, 2002; Forbes et al., 2007).                                   
 
 
Minimum inhibitory concentration (MIC) 
 
Broth dilution method was used to determine the MIC of the test 
agents (Talaro and Talaro, 2002; Forbes et al., 2007). Test agents 
were added as serial dilutions to a series of tubes containing Mueller 
Hinton broth so that the concentrations ranged from 375 to 2.9 µg/ml. 
The bacterial concentration in each tube was 5 × 105 CFU/ml. Three 
kinds of controls, similar to that described above, were also 
prepared. After incubation (37ºC for 24 h), the lowest concentration 
of the agent that led to inhibit the growth of microorganism, was 
considered as MIC.  
 
 
RESULTS AND DISCUSSION 
 
In vitro antibacterial  activity  of  In(CUR)3,  In(DAC)3,  and  
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DAC in comparison with curcumin were investigated 
against S. aureus, S. epidermidis, P. aeruginosa, and E. 
coli (Table 1). The first step of the work was antibacterial 
activity assay with 375 µg/ml of each test agent. Curcumin 
was active against S. aureus and S. epidermidis, whereas 
it did not show antibacterial activity on P. aeruginosa and 
E. coli.  Strikingly, In(CUR)3 exhibited antibacterial effect 
against all the four test organisms. In(DAC)3 was effective 
against S. epidermidis and P. aeruginosa. DAC was not 
found to be effective against the four mentioned bacteria. 
The positive results in the antibacterial activity assay were 
then examined for the determination of MIC (Table 1).  The 
MIC of In(CUR)3 for  S. aureus and S. epidermidis was 
lower than the MIC of the curcumin for these bacteria. 
Furthermore, the MIC of In(CUR)3  for S. epidermidis was 
lower when compared with In(DAC)3. Meanwhile, E. coli 
was inhibited only by In(CUR)3 (MIC: 93.8 µg/ml).  
Curcumin, the main yellow bioactive component of 
turmeric powder, has been shown to have several biolo- 
gical effects such as antimicrobial activity (Chattopadhyay 
et al., 2005; Di Mario et al., 2007). Synthetic modification 
of antibacterial agents in order to improve antibacterial 
activity or pharmacological properties is an interesting field 
in studies. Synthesis of mono-carbonyl analogues of 
curcumin has been reported which some of these 
compounds exhibited more antibacterial activity than cur- 
cumin (Liang et al., 2008). Other researchers attempted to 
synthesis of some bioactive conjugates of curcumin which 
showed relatively more antimicrobial activity than cur- 
cumin itself due to their increased solubility, reduced 
metabolism and better cellular uptake (Mishra et al., 2005; 
Dubey et al., 2007).                                                                
Some metals are known for their antibacterial activity 
and in some cases as effective therapeutic agents against 
bacterial diseases. Indium is a major interest metal with 
antibacterial activity (David et al., 2005). Therefore, two 
new complexes, indium curcumin and indium diacetyl- 
curcumin, were chosen for the present study.                                                              
As shown in Table 1, curcumin was effective against S. 
aureus and S. epidermidis, whereas indium curcumin 
showed antibacterial activity on all the four test organisms. 
Moreover, the MIC of In(CUR)3 for S. aureus and S. 
epidermidis was lower than the MIC of curcumin for the 
same bacterial strains. Therefore, we found an enhance- 
ment in both spectrum and antibacterial activity of indium 
curcumin complex in comparison with curcumin itself. 
There is also similar effectiveness in other metal com- 
pounds such as silver sulfadiazine, a combination of two 
antibacterial agents, Ag+ and sulfadiazine, which has a 
board spectrum of activity; binding to cell components 
such as DNA may be responsible for its inhibitory 
properties (Brooks et al., 2007). Furthermore, it has been 
shown that formation of metal complexes may lead to 
change in ability of uptake them by bacterial cells and thus 
enhance the antibacterial activity (David et al., 2005). 
Therefore, improve in cellular uptake and/or better binding to 
cell components could be the reason for increasing the 
antibacterial effect of indium curcumin.                                                   
3834         Afr. J. Biotechnol. 
 
 
 
Table 1. Antibacterial activity and MIC of curcumin, indium curcumin (In(CUR)3), indium 
diacetylcurcumin (In(DAC)3) and diacetylcurcumin (DAC).  
 
Bacteria Agent Antibacterial activity MIC (µg/ml) 
 curcumin + 187.5 
 In(CUR)3 + 93.8 
 In(DAC)3 –  S. aureus ATCC 25923 
 DAC –  
 curcumin + 46.9 
 In(CUR)3 + 23.4 
 In(DAC)3 + 46.9 
S. epidermidis ATCC 14990 
 
 DAC –  
 curcumin –  
 In(CUR)3 + 23.4 
 In(DAC)3 + 23.4 P. aeruginosa ATCC 27853 
 DAC –  
 curcumin –  
 In(CUR)3 + 93.8 
 In(DAC)3 –  E. coli ATCC 25922 
 DAC –  
 
 
 
In(DAC)3 was found to be active against S. epidermidis 
and P. aeruginosa, but it did not exhibit antibacterial 
activity on S. aureus or E. coli. Thus, although In(DAC)3 
did not inhibit S. aureus, its activity against P. aeruginosa 
is an advantage of this compound over curcumin.    
 
                                                            
In(CUR)3 showed more antibacterial activity than 
In(DAC)3. In fact, the reason which suggests that the 
enhancement in both spectrum and antibacterial activity of 
In(CUR)3 were not due to antibacterial effect of indium 
alone, is that we did not find a similar effect by In(DAC)3. 
Thus, it seems that the roles of both curcumin and indium 
are essential in the action of In(CUR)3.            
In conclusion, indium curcumin complex has more 
antibacterial activity than curcumin and indium diacetyl- 
curcumin, and could be a suitable candidate for further in 
vivo investigations. 
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